These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37714666)

  • 21. Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study.
    Michielsens CAJ; den Broeder N; Mulder MLM; van den Hoogen FHJ; Verhoef LM; den Broeder AA
    Rheumatology (Oxford); 2022 May; 61(6):2307-2315. PubMed ID: 34599803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials.
    Denis A; Sztejkowski C; Arnaud L; Becker G; Felten R
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study.
    Remalante-Rayco P; Espiritu AI; Daghistani Y; Chim T; Atenafu E; Keshavarzi S; Jha M; Gladman DD; Oh J; Haroon N; Inman RD
    Rheumatology (Oxford); 2024 Jul; 63(7):1980-1986. PubMed ID: 37792508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials.
    Keeling S; Maksymowych WP
    Expert Rev Clin Immunol; 2021 Jul; 17(7):701-715. PubMed ID: 33944642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
    Wang S; He Q; Shuai Z
    Clin Rheumatol; 2018 Feb; 37(2):439-450. PubMed ID: 29290076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.
    Hopson S; Gibbs LR; Syed S; Low R; McClung L; Beaty S
    Adv Ther; 2023 Oct; 40(10):4358-4376. PubMed ID: 37486558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study.
    Athanassiou P; Psaltis D; Georgiadis A; Katsifis G; Theodoridou A; Gazi S; Sidiropoulos P; Tektonidou MG; Bounas A; Kandyli A; Vounotrypidis P; Sakellariou GT; Vassilopoulos D; Huang Z; Petrikkou E; Boumpas D
    Rheumatol Int; 2023 Oct; 43(10):1871-1883. PubMed ID: 37402886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta-Analysis.
    Bechman K; Yang Z; Adas M; Nagra D; S Uğuzlar A; Russell MD; Wilson N; Steer S; Norton S; Galloway J
    Arthritis Rheumatol; 2024 May; 76(5):704-714. PubMed ID: 38116697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caesarean section in women with axial spondyloarthritis and psoriatic arthritis: a population-based study.
    Götestam Skorpen C; Lydersen S; Salvesen KÅ; Koksvik HSS; Jakobsen B; Wallenius M
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36863750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark.
    Secher AEP; Granath F; Glintborg B; Rom A; Hetland ML; Hellgren K
    RMD Open; 2022 Nov; 8(2):. PubMed ID: 36328400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation.
    Corbett M; Soares M; Jhuti G; Rice S; Spackman E; Sideris E; Moe-Byrne T; Fox D; Marzo-Ortega H; Kay L; Woolacott N; Palmer S
    Health Technol Assess; 2016 Feb; 20(9):1-334, v-vi. PubMed ID: 26847392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial.
    Proft F; Torgutalp M; Muche B; Rios Rodriguez V; Verba M; Poddubnyy D
    BMJ Open; 2021 Nov; 11(11):e048647. PubMed ID: 34785545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-23 and axial disease: do they come together?
    Mease P; van den Bosch F
    Rheumatology (Oxford); 2021 Oct; 60(Suppl 4):iv28-iv33. PubMed ID: 34668015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.
    Kerola AM; Rollefstad S; Kazemi A; Wibetoe G; Sexton J; Mars N; Kauppi M; Kvien TK; Haavardsholm EA; Semb AG
    Scand J Rheumatol; 2023 Jan; 52(1):42-50. PubMed ID: 35014920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis.
    Rubbert-Roth A; Kakehasi AM; Takeuchi T; Schmalzing M; Palac H; Coombs D; Liu J; Anyanwu SI; Lippe R; Curtis JR
    Rheumatol Ther; 2024 Feb; 11(1):97-112. PubMed ID: 37982966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis.
    Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Englbrecht M; Vorbrüggen W; Adler G; Welcker M
    Rheumatol Int; 2023 Jan; 43(1):89-97. PubMed ID: 36441274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of golimumab on work productivity and quality of life among work-active axial spondyloarthritis and psoriatic arthritis patients treated in the routine care in Greece: the 'GO-UP' study.
    Athanassiou P; Kotrotsios A; Kallitsakis I; Bounas A; Dimitroulas T; Garyfallos A; Tektonidou MG; Vosvotekas G; Livieratos A; Petrikkou E; Katsifis G
    Qual Life Res; 2022 May; 31(5):1385-1399. PubMed ID: 34839451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts.
    de Hooge M; Ishchenko A; De Craemer AS; Steinfeld S; Nzeusseu A; Elewaut D; Lories R; de Vlam K; Van den Bosch F
    RMD Open; 2023 May; 9(2):. PubMed ID: 37137541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in axial spondyloarthritis diagnoses after the introduction of the ASAS criteria: a systematic review.
    Jamal M; van Delft ETAM; den Braanker H; Kuijper TM; Hazes JMW; Lopes Barreto D; Weel AEAM
    Rheumatol Int; 2023 Apr; 43(4):639-649. PubMed ID: 36637486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
    Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.